Ignite Creation Date:
2025-12-25 @ 3:03 AM
Ignite Modification Date:
2026-03-27 @ 8:22 AM
Study NCT ID:
NCT00075933
Status:
COMPLETED
Last Update Posted:
2009-04-28
First Post:
2004-01-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
ARQ 501 in Subjects With Cancer
Sponsor:
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ARQ 501-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None